CHRISTEL MORELLI: Open Payments
NPI 1295812634 · JENKINTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 31 payments from 13 companies in 2025. Trend: 2023 $309 · 2024 $487 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $149 |
| AstraZeneca Pharmaceuticals LP | 6 | $120 |
| Alnylam Pharmaceuticals Inc. | 3 | $60 |
| Boston Scientific Corporation | 1 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $31 |
| PFIZER INC. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Novo Nordisk Inc | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $21 |
Products named: LEQVIO, FARXIGA, ONPATTRO, CDS - MCT/CEM Monitoring, WAINUA, JARDIANCE, LifeVest, VYNDAQEL.
Industry payments across PA — which companies pay providers there.
